MRI-PDFF response in MGL-3196 and placebo treated patients predicts reduction in ballooning and inflammation components of NAS and NASH resolution in a 36-week serial liver biopsy study
Publication
, Conference
Harrison, S; Guy, C; Taub, R; Bashir, M
Published in: JOURNAL OF HEPATOLOGY
April 1, 2019
Duke Scholars
Published In
JOURNAL OF HEPATOLOGY
EISSN
1600-0641
ISSN
0168-8278
Publication Date
April 1, 2019
Volume
70
Issue
1
Start / End Page
E791 / E792
Location
Vienna, AUSTRIA
Publisher
ELSEVIER
Conference Name
International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL)
Related Subject Headings
- Gastroenterology & Hepatology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Harrison, S., Guy, C., Taub, R., & Bashir, M. (2019). MRI-PDFF response in MGL-3196 and placebo treated patients predicts reduction in ballooning and inflammation components of NAS and NASH resolution in a 36-week serial liver biopsy study. In JOURNAL OF HEPATOLOGY (Vol. 70, pp. E791–E792). Vienna, AUSTRIA: ELSEVIER.
Harrison, Stephen, Cynthia Guy, Rebecca Taub, and Mustafa Bashir. “MRI-PDFF response in MGL-3196 and placebo treated patients predicts reduction in ballooning and inflammation components of NAS and NASH resolution in a 36-week serial liver biopsy study.” In JOURNAL OF HEPATOLOGY, 70:E791–92. ELSEVIER, 2019.
Harrison S, Guy C, Taub R, Bashir M. MRI-PDFF response in MGL-3196 and placebo treated patients predicts reduction in ballooning and inflammation components of NAS and NASH resolution in a 36-week serial liver biopsy study. In: JOURNAL OF HEPATOLOGY. ELSEVIER; 2019. p. E791–2.
Harrison, Stephen, et al. “MRI-PDFF response in MGL-3196 and placebo treated patients predicts reduction in ballooning and inflammation components of NAS and NASH resolution in a 36-week serial liver biopsy study.” JOURNAL OF HEPATOLOGY, vol. 70, no. 1, ELSEVIER, 2019, pp. E791–92.
Harrison S, Guy C, Taub R, Bashir M. MRI-PDFF response in MGL-3196 and placebo treated patients predicts reduction in ballooning and inflammation components of NAS and NASH resolution in a 36-week serial liver biopsy study. JOURNAL OF HEPATOLOGY. ELSEVIER; 2019. p. E791–E792.
Published In
JOURNAL OF HEPATOLOGY
EISSN
1600-0641
ISSN
0168-8278
Publication Date
April 1, 2019
Volume
70
Issue
1
Start / End Page
E791 / E792
Location
Vienna, AUSTRIA
Publisher
ELSEVIER
Conference Name
International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL)
Related Subject Headings
- Gastroenterology & Hepatology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1103 Clinical Sciences